| Abstrakt: |
Background: Endocrine-disrupting effects of phthalates are understood primarily from in utero exposures within the fetal rat testis. Nevertheless, their path of action, dose-response character, and cellular target(s) within the fetal testis are not known. Objectives: In this study we investigated the effects of di-(2-ethylhexyl) phthalate (DEHP), mono- (2-ethylhexyl) phthalate (MEHP), and several of their metabolites on the development of organocultured testes from rat fetus. Methods: We removed testes from 14.5-day-old rat fetuses and cultured them for 1-3 days with or without DEHP, MEHP, and the metabolites. Results: DEHP (10-5 M) produced a proandrogenic effect after 3 days of culture, whereas MEHP disrupted testis morphology and function. Leydig cells were the first affected by MEHP, with a number of them being inappropriately located within some seminiferous tubules. Additionally, we found a time- and dose-dependent reduction of testosterone. By 48 hr, gonocyte proliferation had decreased, whereas apoptosis increased. Sertoli cell number was unaffected, although some cells appeared vacuolated, and production of anti-Müllerian hormone decreased in a time- and dosedependent manner. The derived metabolite mono-(2-ethyl-5-hydroxyhexyl) phthalate was the only one to cause deleterious effects to the rat fetal testis in vitro. Conclusion: We hope that this in vitro method will facilitate the study of different phthalate esters and other endocrine disruptors for direct testicular effects. [ABSTRACT FROM AUTHOR] |
